
Sign up to save your podcasts
Or


Dr Adam Brufsky from the University of Pittsburgh discusses the latest clinical data on HER2-targeted therapy for the management of HER2-positive localized breast cancer.
CME information and select publications here.
By Research To Practice5
66 ratings
Dr Adam Brufsky from the University of Pittsburgh discusses the latest clinical data on HER2-targeted therapy for the management of HER2-positive localized breast cancer.
CME information and select publications here.

66 Listeners

30 Listeners

75 Listeners

14 Listeners

17 Listeners

4 Listeners

2 Listeners

12 Listeners

0 Listeners

122 Listeners